Literature DB >> 11122939

Bipolar disorder in youth.

G A Carlson1, S E Meyer.   

Abstract

The debate regarding the possible existence of prepubertal bipolar illness has surfaced at various points in history. In its most recent incarnation, proponents of a childhood bipolar diagnosis argue that there is an early-onset form of bipolar illness that is highly comorbid and characterized by simultaneous irritability and depression. Others have suggested that childhood manic symptoms are more likely a nonspecific indicator of risk, or may be the result of symptom overlap with various other forms of childhood pathology. This article briefly reviews pertinent findings from epidemiologic, developmental, family, and treatment studies that shed light on the etiology, phenomenology, and developmental significance of manic symptoms in young people.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122939     DOI: 10.1007/s11920-000-0051-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  72 in total

1.  More on valproate and polycystic ovaries.

Authors:  H F Johnston
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-04       Impact factor: 8.829

2.  Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands.

Authors:  R D Todd; W Reich; T A Petti; P Joshi; J R DePaulo; J Nurnberger; T Reich
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-05       Impact factor: 8.829

3.  Antecedents and complications of trauma in boys with ADHD: findings from a longitudinal study.

Authors:  J Wozniak; M H Crawford; J Biederman; S V Faraone; T J Spencer; A Taylor; H K Blier
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-01       Impact factor: 8.829

4.  Nimodipine treatment of an adolescent with ultradian cycling bipolar affective illness.

Authors:  P A Davanzo; N Krah; J Kleiner; J McCracken
Journal:  J Child Adolesc Psychopharmacol       Date:  1999       Impact factor: 2.576

5.  Obstetrical complications in patients with bipolar disorder and their siblings.

Authors:  D K Kinney; D A Yurgelun-Todd; D L Levy; D Medoff; C M Lajonchere; M Radford-Paregol
Journal:  Psychiatry Res       Date:  1993-07       Impact factor: 3.222

6.  Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?

Authors:  S V Faraone; J Biederman; D Mennin; J Wozniak; T Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

7.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

8.  Children with prepubertal-onset major depressive disorder and anxiety grown up.

Authors:  M M Weissman; S Wolk; P Wickramaratne; R B Goldstein; P Adams; S Greenwald; N D Ryan; R E Dahl; D Steinberg
Journal:  Arch Gen Psychiatry       Date:  1999-09

9.  Mixed mania associated with tricyclic antidepressant therapy in prepubertal delusional depression: three cases.

Authors:  M Strober
Journal:  J Child Adolesc Psychopharmacol       Date:  1998       Impact factor: 2.576

10.  Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds.

Authors:  B Geller; L W Fox; M Fletcher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-01       Impact factor: 8.829

View more
  1 in total

1.  Longitudinal Assessment of Manic Symptoms (LAMS) study: background, design, and initial screening results.

Authors:  Sarah McCue Horwitz; Christine A Demeter; Maria E Pagano; Eric A Youngstrom; Mary A Fristad; L Eugene Arnold; Boris Birmaher; Mary Kay Gill; David Axelson; Robert A Kowatch; Thomas W Frazier; Robert L Findling
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.